Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Peter J. Espenshade

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6433-0178; OpenAlex author ID A5008400892; NIH RePORTER profile ID 2048139. Sources: funder_awards.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
3
Labs led
1
Collaborators
7
Papers, trials and grants by year

2012: 1 grant · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 grant · 2022: none · 2023: none · 2024: 2 papers, 1 grant

Papers 2

  1. In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency. Last author DOI 10.1016/j.molmet.2024.101964↗
  2. SREBP-Dependent Regulation of Lipid Homeostasis Is Required for Progression and Growth of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/2767-9764.crc-24-0120↗

Grants 3

  1. High Throughput Screening for SCAP Inhibitors as Pancreas Cancer Therapeutics R01CA272789↗
  2. Lipid Regulation of Hypoxia-inducible Factors R01GM126088↗
  3. SREBP Pathway as a Target for Pancreatic Cancer Therapy AWARD pancan:2012-peter-espenshade-phd-srebp-pathway-as-a-target-for-pancreatic

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Casie S. Kubota · 2 shared papers, 2024 · strength 0.47
  2. Toni T. Seppälä · 1 shared paper, 2024 · strength 0.28
  3. Richard Andrew Burkhart · 1 shared paper, 2024 · strength 0.28
  4. Robert A. Anders · 1 shared paper, 2024 · strength 0.19
  5. Hao Wang · 1 shared paper, 2024 · strength 0.19
  6. Zeshaan A. Rasheed · 1 shared paper, 2024 · strength 0.19
  7. Chiaki T. Ishida · 1 shared paper, 2024 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.